179 related articles for article (PubMed ID: 20964625)
1. Translational control gone awry: a new mechanism of tumorigenesis and novel targets of cancer treatments.
Yin JY; Dong Z; Liu ZQ; Zhang JT
Biosci Rep; 2011 Feb; 31(1):1-15. PubMed ID: 20964625
[TBL] [Abstract][Full Text] [Related]
2. Initiation factor eIF3 and regulation of mRNA translation, cell growth, and cancer.
Dong Z; Zhang JT
Crit Rev Oncol Hematol; 2006 Sep; 59(3):169-80. PubMed ID: 16829125
[TBL] [Abstract][Full Text] [Related]
3. The role of translation in neoplastic transformation from a pathologist's point of view.
Rosenwald IB
Oncogene; 2004 Apr; 23(18):3230-47. PubMed ID: 15094773
[TBL] [Abstract][Full Text] [Related]
4. Cap-dependent translation and control of the cell cycle.
Cormier P; Pyronnet S; Salaün P; Mulner-Lorillon O; Sonenberg N
Prog Cell Cycle Res; 2003; 5():469-75. PubMed ID: 14593742
[TBL] [Abstract][Full Text] [Related]
5. Role of eIF3 p170 in controlling synthesis of ribonucleotide reductase M2 and cell growth.
Dong Z; Liu LH; Han B; Pincheira R; Zhang JT
Oncogene; 2004 May; 23(21):3790-801. PubMed ID: 15094776
[TBL] [Abstract][Full Text] [Related]
6. Translational control of malignancy: the mRNA cap-binding protein, eIF-4E, as a central regulator of tumor formation, growth, invasion and metastasis.
Zimmer SG; DeBenedetti A; Graff JR
Anticancer Res; 2000; 20(3A):1343-51. PubMed ID: 10928042
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of ribosomal subunit joining during eukaryotic translation initiation.
Acker MG; Lorsch JR
Biochem Soc Trans; 2008 Aug; 36(Pt 4):653-7. PubMed ID: 18631135
[TBL] [Abstract][Full Text] [Related]
8. The tumor-selective over-expression of the human Hsp70 gene is attributed to the aberrant controls at both initiation and elongation levels of transcription.
Cai L; Zhu JD
Cell Res; 2003 Apr; 13(2):93-109. PubMed ID: 12737518
[TBL] [Abstract][Full Text] [Related]
9. Eukaryotic translation initiation factors as promising targets in cancer therapy.
Hao P; Yu J; Ward R; Liu Y; Hao Q; An S; Xu T
Cell Commun Signal; 2020 Nov; 18(1):175. PubMed ID: 33148274
[TBL] [Abstract][Full Text] [Related]
10. Targets and mechanisms for the regulation of translation in malignant transformation.
Clemens MJ
Oncogene; 2004 Apr; 23(18):3180-8. PubMed ID: 15094767
[TBL] [Abstract][Full Text] [Related]
11. On translational regulation and EMT.
Evdokimova V; Tognon CE; Sorensen PH
Semin Cancer Biol; 2012 Oct; 22(5-6):437-45. PubMed ID: 22554796
[TBL] [Abstract][Full Text] [Related]
12. The causes of cancer revisited: "mitochondrial malignancy" and ROS-induced oncogenic transformation - why mitochondria are targets for cancer therapy.
Ralph SJ; Rodríguez-Enríquez S; Neuzil J; Saavedra E; Moreno-Sánchez R
Mol Aspects Med; 2010 Apr; 31(2):145-70. PubMed ID: 20206201
[TBL] [Abstract][Full Text] [Related]
13. Translational control of eukaryotic gene expression.
Van Der Kelen K; Beyaert R; Inzé D; De Veylder L
Crit Rev Biochem Mol Biol; 2009; 44(4):143-68. PubMed ID: 19604130
[TBL] [Abstract][Full Text] [Related]
14. Regulation of ornithine decarboxylase in a transformed cell line that overexpresses translation initiation factor eIF-4E.
Shantz LM; Hu RH; Pegg AE
Cancer Res; 1996 Jul; 56(14):3265-9. PubMed ID: 8764119
[TBL] [Abstract][Full Text] [Related]
15. The Akt of translational control.
Ruggero D; Sonenberg N
Oncogene; 2005 Nov; 24(50):7426-34. PubMed ID: 16288289
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
[TBL] [Abstract][Full Text] [Related]
17. Translation regulation as a therapeutic target in cancer.
Grzmil M; Hemmings BA
Cancer Res; 2012 Aug; 72(16):3891-900. PubMed ID: 22850420
[TBL] [Abstract][Full Text] [Related]
18. Aberrant protein synthesis and cancer development: The role of canonical eukaryotic initiation, elongation and termination factors in tumorigenesis.
Rubio A; Garland GD; Sfakianos A; Harvey RF; Willis AE
Semin Cancer Biol; 2022 Nov; 86(Pt 3):151-165. PubMed ID: 35487398
[TBL] [Abstract][Full Text] [Related]
19. The regulation of protein synthesis in cancer.
Cuesta R; Gupta M; Schneider RJ
Prog Mol Biol Transl Sci; 2009; 90():255-92. PubMed ID: 20374744
[TBL] [Abstract][Full Text] [Related]
20. Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5' cap.
Lazaris-Karatzas A; Montine KS; Sonenberg N
Nature; 1990 Jun; 345(6275):544-7. PubMed ID: 2348862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
